Zaïde Frias joined the European Medicines Agency (EMA) in 1999; she was appointed Head of Regulatory Affairs in 2009 and became the Head of Human Medicines Research and Development Support Division in 2013.
In September 2016 she was appointed as Head of Human Medicines Evaluation Division at EMA. This Division is responsible for activities related to the scientific, regulatory and procedural management of human medicines evaluation, including risk management and product information. For centrally authorised products it provides support to Scientific Committees, Working parties and SAGs on product life-cycle activities across therapeutic areas, covering pre-submission to the post-authorisation phase. In relation to nationally authorised products it is in charge of coordinating referral and PSUR procedures.
Zaïde Frias has degrees in Pharmacy and Business Administration. Prior to joining EMA, she worked in Pharmaceutical Industry.